The Top Biotech ETF To Buy Right Now [First Trust NYSE Arca Biotchnlgy Indx Fd, iShares NASDAQ Biotechnology Index (ETF)]

biotechKyle Anderson: Our favorite biotech ETF has been one of the biggest winners of this sector's 2015 rally…
NASDAQ:BIB June 15, 2015 2:51pm

Changing The Face Of Biotech Investing [iShares NASDAQ Biotechnology Index (ETF), Market Vectors Pharmaceutical ETF]

biotechLawrence Meyers: If you’re interested in seeking out investments in new biotechnology and pharmaceutical advances that could change the face of health care, then you may want to look at some ETFs that may take advantage of the advance in biosimilars.
NASDAQ:IBB June 1, 2015 2:20pm

Pharma’s Record Setting First Quarter [Actavis plc, Allergan, Inc., Eli Lilly and Co, Novartis AG (ADR), AbbVie Inc]

biotechKyle Anderson: The pharmaceutical industry saw record-setting M&A activity in the first quarter of 2015.
NYSE:XPH May 12, 2015 12:37pm

Amgen, Inc., Gilead Sciences, Inc., Biogen Inc, Celgene Corporation: Is A Biotech Bubble Looming?

dollar money bubbleJay Taylor: If you own shares of biotechnology stocks, chances are you’re having a great 2015.
NASDAQ:BIB April 14, 2015 2:55pm

Gilead Sciences, Inc., Amgen, Inc., Biogen Inc: Is This A Biotech Bubble?

dollar money bubbleKyle Anderson: Wall Street pundits are claiming we are on the precipice of a biotech bubble because biotechnology stocks have been soaring.
NASDAQ:BIB April 1, 2015 2:55pm

Biotechs With Massive Upside [BioCryst Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., AbbVie Inc]

biotechEverybody knows that biotech ideas can become huge gainers for investors, but understanding the technology platforms, the unmet needs and the valuations can be daunting, especially in spaces where a number of players are developing products.
NASDAQ:BIB September 15, 2014 2:08pm

ETF Impact On Biotech Earnings [Celgene Corporation, Alexion Pharmaceuticals, Inc., Amgen, Inc., Biogen Idec Inc]

biotechnologyThe Q2 earnings season has so far been great for biotech companies with most of them giving solid quarterly updates. Biotech giant Gilead Sciences (GILD) continued with its exceptional performance in this quarter as well, beating the Zacks Consensus Estimate
NASDAQ:BIB July 31, 2014 4:23pm

Biotechs With High Reward Potential [Biogen Idec Inc, Inovio Pharmaceuticals Inc, StemCells Inc, Gilead Sciences, Inc.]

biotechA biotech analyst could play it safe, and stick with mid-, late- and commercial-stage companies that offer higher odds and decent returns on good news. Christopher James, on the other hand, recommends that investors willing to diversify their holdings

Gilead Sciences, Inc. (GILD): The Bullish Case For The Stock

biotechKyle Anderson: Gilead Sciences Inc. (NASDAQ:GILD) stock hit a 52-week high of $92.97 this morning (Thursday) after the company crushed earnings estimates last night. At that price, GILD stock has climbed 3% from yesterday's close.
NASDAQ:BIB July 28, 2014 3:05pm

Why I’m Bullish On Gilead Sciences, Inc. (GILD)

bullish buyTyler Laundon: Biotech bears were tearing apart the sector in Q1 of this year. And it got ugly.

Invest In These Alternatives To Biotech [Becton, Dickinson and Co., Medtronic, Inc., Johnson & Johnson]

biotechnologyBill Hall:  The alarm bells went off on Wall Street last week as Federal Reserve Chair Janet Yellen warned of a bubble in social media and biotech stocks. Indeed, in her public comments last week, Yellen stated that biotechnology valuations are “stretched,
NASDAQ:IBB July 23, 2014 4:31pm

The Biggest Beneficiary Of Biotech’s Comeback [Gilead Sciences, Inc., Idenix Pharmaceuticals Inc, Merck & Co., Inc.]

money and investingMichael Robinson: Late last month, I told you that biotech is one of the best ways to profit from the tech rebound. In fact, it was my "No Doz Opportunity No. 1."
NASDAQ:BIB July 10, 2014 3:20pm

The Biotech Bull Market Is Far From Over [Inovio Pharmaceuticals Inc, Gilead Sciences, Inc., Ariad Pharmaceuticals, Inc.]

biotechThe biotech bull market is not over. That's the judgment of Reni Benjamin of H.C. Wainwright & Co., who predicts high quality data from a broad range of small- and mid-cap biotechs will move shares higher during the summer and especially in the fall.

Biotech ETF (IBB) Selling Off On High Volume [iShares NASDAQ Biotechnology Index (ETF)]

sellbuyMorpheus Trading: Monday saw some profit taking in extended industry ETFs, most notably the Biotech ETF (NASDAQ:IBB), which closed -2.6% lower on a pickup in volume.
NASDAQ:BIB July 8, 2014 12:41pm

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular

From Our Partners

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories